[1] Jouret G,Poirsier C,Spodenkiewicz M,et al.Genetics of Usher Syndrome:New insights from a meta-analysis[J].O-tology&Neurotology,2019,40(1):121-129．

[2] Abadie C,Blanchet C,Baux D,et al.Audiological findings in 100 USH2patients[J].Clinical Genetics,2012,82(5):433-438．

[3] Blanco-Kelly F,Jaijo T,Aller E,et al.Clinical aspects of Usher syndrome and the USH2Agene in a cohort of 433patients[J].JAMA Ophthalmology,2015,133(2):157-164．

[4] Hartel B,Van Nierop J,Huinck W,et al.Cochlear implantation in patients with usher syndrome type IIa increases performance and quality of life[J].Otology&Neurotology,2017,38(6):e120-e127．

[5] Le Quesne Stabej P,Saihan Z,Rangesh N,et al.Comprehensive sequence analysis of nine Usher syndrome genes in the UK National Collaborative Usher Study[J].Journal of Medical Genetics,2012,49(1):27-36．

[6] Puffenberger EG,Jinks RN,Carrie S,et al.Genetic mapping and exome sequencing identify variants associated with five novel diseases[J].Plos One,2012,7(1):e28936.DOI:10.1371/journal.pone.0028936

[7] Abad-Morales V,Navarro R,Bures-Jelstrup A,et al.Identification of a novel homozygous ARSG mutation as the second cause of Usher syndrome type 4[J].Am J Ophthalmol Case Rep,2020,19:100736.DOI:10.1016/j.ajoc.2020.100736

[8] Lenassi E,Saihan Z,Bitner-Glindzicz M,et al.The effect of the common c.2299delG mutation in USH2Aon RNA splicing[J].Experimental Eye Research,2014,122:9-12．

[9] Lenassi E,Robson A,Luxon L,et al.Clinical heterogeneity in a family with mutations in USH2A[J].JAMA Ophthal Mology,2015,133(3):352-355．

[10] Lenassi E,Vincent A,Li Z,et al.A detailed clinical and molecular survey of subjects with nonsyndromic USH2Aretinopathy reveals an allelic hierarchy of disease-causing variants[J].European Journal of Human Genetics,2015,23(10):1318-1327．

[11] Molina-Ramírez L,Lenassi E,Ellingford J,et al.Establishing genotype-phenotype correlation in USH2A-related Disorders to personalize audiological surveillance and rehabilitation[J].Otology&Neurotology,2020,41(4):431-437．

[12] Pérez-Carro R,Blanco-Kelly F,Galbis-Martínez L,et al.Unravelling the pathogenic role and genotype-phenotype correlation of the USH2Ap.(Cys759Phe)variant among Spanish families[J].PLoS One,2018,13(6):e0199048.DOI:10.1371/journal.pone.0199048

[13] Zallocchi M,Binley K,Lad Y,et al.EIAV-based retinal gene therapy in the shaker1mouse model for usher syndrome type 1B:development of UshStat[J].PLoS One,2014,9(4):e94272.DOI:10.1371/journal.pone.0094272

[14] Sanjurjo-Soriano C,Erkilic N,Baux D,et al.USH2AGenome editing in patient iPSCs corrects the most prevalent mutations and reveals intriguing mutant mRNA expression profiles[J].Molecular Therapy.Methods&Clinical Development,2020,17:156-173.DOI:10.1016/j.omtm.2019.11.016

[15] Alagramam KN,Gopal SR,Geng R,et al.A small molecule mitigates hearing loss in a mouse model of Usher syndrome III[J].Nature Chemical Biology,2016,12(6):444-451．

[16] Depreux F,Wang L,Jiang H,et al.Antisense oligonucleotides delivered to the amniotic cavity in utero modulate gene expression in the postnatal mouse[J].Nucleic Acids Research,2016,44(20):9519-9529．

[17] Wang L,Kempton J,Jiang H,et al.Fetal antisense oligonucleotide therapy for congenital deafness and vestibular dysfunction[J].Nucleic Acids Research,2020,48(9):5065-5080．

[18] Terrell D,Comander J.Current stem-cell approaches for the treatment of inherited retinal degenerations[J].Seminars in Ophthalmology,2019,34(4):287-292．

[19] Weiss J,Levy S.Stem cell ophthalmology treatment study(SCOTS):bone marrow derived stem cells in the treatment of Usher syndrome[J].Stem Cell Investigation,2019,6:31.DOI:10.21037/sci.2019.08.07

[20] Xu L,Bolch S,Santiago C,et al.Clarin-1expression in adult mouse and human retina highlights a role of Müller glia in Usher syndrome[J].The Journal of Pathology,2020,250(2):195-204.